Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Protagonist Therapeutics Inc (NASDAQ: PTGX) closed the day trading at $42.01 down -5.13% from the previous closing price of $44.28. In other words, the price has decreased by -$5.13 from its previous closing price. On the day, 0.81 million shares were traded.
Ratios:
For a better understanding of PTGX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.11. For the most recent quarter (mrq), Quick Ratio is recorded 12.48 and its Current Ratio is at 12.48. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 06, 2024, initiated with a Neutral rating and assigned the stock a target price of $47.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $62.
On November 05, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $58.Wedbush initiated its Outperform rating on November 05, 2024, with a $58 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 22 ’25 when Ali Asif sold 1,756 shares for $46.00 per share. The transaction valued at 80,776 led to the insider holds 61,065 shares of the business.
Waddill William D. sold 4,000 shares of PTGX for $217,000 on Mar 17 ’25. The Director now owns 13,130 shares after completing the transaction at $54.25 per share. On Mar 17 ’25, another insider, WILLIAM D WADDILL, who serves as the Director of the company, bought 4,000 shares for $54.78 each.
Valuation Measures:
As of this moment, Protagonist’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.99. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.94 while its Price-to-Book (P/B) ratio in mrq is 3.80.
Stock Price History:
Over the past 52 weeks, PTGX has reached a high of $60.60, while it has fallen to a 52-week low of $25.23. The 50-Day Moving Average of the stock is -9.05%, while the 200-Day Moving Average is calculated to be -1.74%.
Shares Statistics:
A total of 61.04M shares are outstanding, with a floating share count of 57.87M. Insiders hold about 5.73% of the company’s shares, while institutions hold 99.70% stake in the company.
